153 related articles for article (PubMed ID: 17548166)
1. Bioinformatics analysis of diabetic retinopathy using functional protein sequences.
Rao AA; Thota H; Gumpeny RS; Akula A; Changalasetty SB; Challa SR; Ravavarapu T; Akula SP; Divakar Ch; Srinivas K; Das UN
Med Hypotheses; 2008; 70(1):148-55. PubMed ID: 17548166
[TBL] [Abstract][Full Text] [Related]
2. Genes and diabetic retinopathy.
Radha V; Rema M; Mohan V
Indian J Ophthalmol; 2002 Mar; 50(1):5-11. PubMed ID: 12090088
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase and diabetic retinopathy.
Singh R; Dash D; Ansari FJ; Maurya OP; Singh VP
Ann Ophthalmol; 1992 Nov; 24(11):420-2. PubMed ID: 1476398
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of microvascular disease in diabetic retinopathy.
Warpeha KM; Chakravarthy U
Eye (Lond); 2003 Apr; 17(3):305-11. PubMed ID: 12724690
[TBL] [Abstract][Full Text] [Related]
5. [Genetics of diabetic complications: retinopathy].
Taverna MJ
Ann Endocrinol (Paris); 2004 Feb; 65(1 Suppl):S17-25. PubMed ID: 15163920
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiology, pathogenesis and therapy of diabetic retinopathy and maculopathy].
Jochmann C; Hammes HP
Z Arztl Fortbild Qualitatssich; 2002 Mar; 96(3):167-74. PubMed ID: 12017760
[TBL] [Abstract][Full Text] [Related]
7. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
[TBL] [Abstract][Full Text] [Related]
8. Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in southern India.
Uthra S; Raman R; Mukesh BN; Padmaja Kumari R; Paul PG; Lakshmipathy P; Gnanamoorthy P; Sharma T; McCarty CA; Kumaramanickavel G
Ophthalmic Genet; 2007 Jun; 28(2):77-81. PubMed ID: 17558849
[TBL] [Abstract][Full Text] [Related]
9. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
10. Current approaches and perspectives in the medical treatment of diabetic retinopathy.
Porta M; Allione A
Pharmacol Ther; 2004 Aug; 103(2):167-77. PubMed ID: 15369682
[TBL] [Abstract][Full Text] [Related]
11. Deletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generation.
Tang J; Du Y; Petrash JM; Sheibani N; Kern TS
PLoS One; 2013; 8(4):e62081. PubMed ID: 23614016
[TBL] [Abstract][Full Text] [Related]
12. Focus on molecules: aldose reductase.
Anil Kumar P; Bhanuprakash Reddy G
Exp Eye Res; 2007 Dec; 85(6):739-40. PubMed ID: 16997295
[No Abstract] [Full Text] [Related]
13. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in Type 2 diabetes in Caucasians.
Petrovic MG; Peterlin B; Hawlina M; Petrovic D
J Diabetes Complications; 2005; 19(2):70-3. PubMed ID: 15745835
[TBL] [Abstract][Full Text] [Related]
15. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
Pan HZ; Zhang H; Chang D; Li H; Sui H
Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071
[TBL] [Abstract][Full Text] [Related]
16. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy.
Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY
Clin Endocrinol (Oxf); 2008 Apr; 68(4):542-6. PubMed ID: 17973941
[TBL] [Abstract][Full Text] [Related]
17. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
Liinamaa MJ; Savolainen MJ
Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886
[TBL] [Abstract][Full Text] [Related]
18. [Molecular basis of diabetic retinopathy].
Rusin P; Majsterek I
Postepy Hig Med Dosw (Online); 2007 Dec; 61():786-96. PubMed ID: 18097337
[TBL] [Abstract][Full Text] [Related]
19. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
[TBL] [Abstract][Full Text] [Related]
20. A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes.
Kao YL; Donaghue K; Chan A; Knight J; Silink M
Diabetes; 1999 Jun; 48(6):1338-40. PubMed ID: 10342825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
